MetaCap

Cadrenal Therapeutics (CVKD) vs Alaunos Therapeutics (TCRT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cadrenal Therapeutics is the larger company by market cap ($7.0 million vs $7.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVKD+74.84%TCRT+98.07%
+288%+132%-24%
Oct 7, 20261 yearNov 20, 2026
CVKD+86.79%TCRT+111.25%
+246%+117%-12%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVKD versus TCRT key metrics
MetricCVKDTCRT
Share price$1.70$1.66
Market cap$7.01M$6.99M
1-day change+0.59%+3.75%
EPS (TTM)$-3.67$-1.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$5.00K
Revenue growth (YoY)—-50.00%
Net income (latest FY)$-13.24M$-4.18M
Operating margin—-84500.00%
Net margin—-83520.00%
52-week high$12.50$4.50
52-week low$0.816$0.72
Distance from 52-week high-86.40%-63.11%
Analyst consensusnone—
Avg. price target upside+723.53%—
Average volume496.14K7.56M
Shares outstanding4.12M4.21M
Employees51
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Cadrenal Therapeutics

CVKD stock →

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Alaunos Therapeutics

TCRT stock →

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

CVKD vs TCRT FAQ

Which is bigger, Cadrenal Therapeutics or Alaunos Therapeutics?

Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $7.01M compared with $6.99M for Alaunos Therapeutics (TCRT).

Are Cadrenal Therapeutics and Alaunos Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons